Literature DB >> 10720059

A human pituitary tumor-derived folliculostellate cell line.

D C Danila1, X Zhang, Y Zhou, G R Dickersin, J A Fletcher, E T Hedley-Whyte, M K Selig, S R Johnson, A Klibanski.   

Abstract

Pituitary cells have been used for the study of hormone synthesis, secretion, and regulation. However, the lack of human cell lines of pituitary origin has made such studies in humans very difficult. Activin, a member of the transforming growth factor-beta cytokine family, is secreted by the pituitary and serves, in addition to regulating hormone biosynthesis, as a regulator of cell growth and differentiation. In the human pituitary, folliculo-stellate cells secrete an activin-binding and -neutralizing protein, follistatin. However, the role of these cells in the autocrine/paracrine regulatory mechanisms of activin is poorly understood. We describe a human pituitary-derived folliculostellate cell line, designated PDFS, that was developed spontaneously from a clinically nonfunctioning pituitary macroadenoma. PDFS cells showed an epithelial-like morphology with long cytoplasmic processes. Electron microscopy revealed frequent intercellular junctions, including desmosomes, and cytogenetic analysis showed clonal characteristics with chromosomal abnormalities. These cells express vimentin and the nervous tissue-specific S-100 protein, specific markers of folliculostellate cells in the anterior pituitary, but no secretory pituitary cell markers. PDFS cells formed large colonies in an anchorage-independent transformation assay. They express follistatin and activin A and have an intact activin intracellular signaling pathway as determined by reporter assays. Therefore, this human cell line provides a useful model for studying the regulation of cell growth and cytokine production by factors endogenously produced in pituitary folliculostellate cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720059     DOI: 10.1210/jcem.85.3.6424

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

2.  Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells.

Authors:  Aurora Aiello; Maria Francesca Cassarino; Simona Nanni; Antonella Sesta; Francesco Ferraú; Claudio Grassi; Marco Losa; Francesco Trimarchi; Alfredo Pontecorvi; Salvatore Cannavò; Francesca Pecori Giraldi; Antonella Farsetti
Journal:  Endocrine       Date:  2017-04-26       Impact factor: 3.633

3.  Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kolja Wawrowsky; Yuji Tani; Anat Ben-Shlomo; Vladimir Ljubimov; Adam Mamelak; Serguei Bannykh; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2012-10-09

Review 4.  MEG3 noncoding RNA: a tumor suppressor.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  J Mol Endocrinol       Date:  2012-04-02       Impact factor: 5.098

Review 5.  Common tools for pituitary adenomas research: cell lines and primary cells.

Authors:  Ziyan Zhu; Weiwei Cui; Dimin Zhu; Nailin Gao; Yonghong Zhu
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

6.  Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas.

Authors:  Pornsuk Cheunsuchon; Yunli Zhou; Xun Zhang; Hang Lee; Wendy Chen; Yuki Nakayama; Kimberley A Rice; E Tessa Hedley-Whyte; Brooke Swearingen; Anne Klibanski
Journal:  Am J Pathol       Date:  2011-08-24       Impact factor: 4.307

7.  High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors.

Authors:  Wenxiu Zhao; Xiaobin Jiang; Karrin Weisenthal; Jun Ma; Erin M Botticelli; Yunli Zhou; E Tessa Hedley-Whyte; Baiyao Wang; Brooke Swearingen; Roy J Soberman; Anne Klibanski; Xun Zhang
Journal:  Front Oncol       Date:  2022-05-13       Impact factor: 5.738

8.  CircVPS13C promotes pituitary adenoma growth by decreasing the stability of IFITM1 mRNA via interacting with RRBP1.

Authors:  Weiyu Zhang; Siyu Chen; Qiu Du; Piaopiao Bian; Yutong Chen; Zexian Liu; Jian Zheng; Ke Sai; Yonggao Mou; Zhongping Chen; Xiang Fan; Xiaobing Jiang
Journal:  Oncogene       Date:  2022-01-28       Impact factor: 8.756

9.  Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.

Authors:  Paweena Chunharojrith; Yuki Nakayama; Xiaobing Jiang; Rachel E Kery; Jun Ma; Cristine S De La Hoz Ulloa; Xun Zhang; Yunli Zhou; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2015-08-15       Impact factor: 4.102

10.  Isolation of tumour stem-like cells from benign tumours.

Authors:  Q Xu; X Yuan; P Tunici; G Liu; X Fan; M Xu; J Hu; J Y Hwang; D L Farkas; K L Black; J S Yu
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.